Abbott
Trade Abbott 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABT
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
ABT Key Statistics
ABT News
Advertisement Abbott Laboratories ( ) First Quarter 2025 Results Key Financial Results Revenue: US$10.4b (up 4.0% from 1Q 2024). Net income: US$1.33b (up 8....
Bernstein analyst Lee Hambright has maintained their bullish stance on ABT stock, giving a Buy rating today. Lee Hambright has given his Buy rating due to a co...
Stifel raised the firm’s price target on Abbott (ABT) to $145 from $135 and keeps a Buy rating on the shares. Abbott’s resilient Q1 performance, reiterated 2025...
Analyst ratings
66%
of 29 ratingsMore ABT News
Abbott Laboratories ( (ABT) ) has released its Q1 earnings. Here is a breakdown of the information Abbott Laboratories presented to its investors. Abbott Labor...
In a report released yesterday, Josh Jennings from TD Cowen reiterated a Buy rating on Abbott Laboratories (ABT – Research Report), with a price target of $145....
recently reported positive Q1 2025 results, showing increased sales and net income, which may have bolstered its share price by 14% last quarter. The enhanced f...
U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 2% on Wednesday. The Dow traded down 0.67% to 40,099.73 while the NASDAQ dipped 2...
Abbott Laboratories ABT on Wednesday reported first-quarter sales of $10.36 billion, up 7.2% year over year, almost in line with the consensus of $10.40 billion...
U.S. stock futures moved lower Wednesday as investors braced for another wave of geopolitical and earnings headlines. S&P 500 futures were down 0.5%, the Dow ho...
Abbott Laboratories (ABT) stock slipped on Wednesday after the healthcare company reported its Q1 2025 earnings. Its adjusted earnings per share for the quarter...